FOXL2 and gastric carcinoma: Yu et al. [30] reported that miR-937 was decreased in patients with gastric carcinoma, and further exploration demonstrated that miR-937 can regulate FOXL2 by suppressing the PI3K/AKT signaling pathway to inhibit the proliferation and metastasis of gastric carcinoma cells.